A groundbreaking study by PerMe’s Prof. Gil Atzmon has revealed a genetic variation in the GHR gene—known as d3GHR—that could explain why some people are more resilient to ageing and stress. Using cutting-edge CRISPR technology, scientists discovered that cells with this variation survive better under stressful conditions, like UV radiation and fasting, compared to regular cells. 💡 This discovery shows how specific genetic traits can impact ageing and stress resilience. 💡 With advancements like PerMe's DNA profiling, you can uncover unique insights about your own genetics—helping you take steps toward a healthier, longer life. At PerMe, we’re turning complex genetic science into simple, actionable insights for everyone. Instant results, no lab trips, and a better understanding of your health—all in the palm of your hand! Assaf TidharYoav RapaportShaul RachmaniDr. Carina TyrrellIgal ChertkowChen Amar HassonGil Atzmon
עלינו
PerMe stands at the forefront of health technology, pioneering the world's first digital DNA test. By converting biological samples into digital data, we're revolutionizing DNA diagnostics. Our device is affordable, instantaneous, and lab-free, providing access from the convenience of your home or any point of care, anytime, anywhere. Compact and disposable, it requires no power source. Effortlessly, we decode genes and molecules from saliva and other non-invasive samples, transmitting results wirelessly to your smartphone in real-time. Whether it's identifying cancer-associated genes, detecting infectious diseases, or offering tailored skincare recommendations, PerMe is democratising DNA testing, making it accessible to all.
- אתר אינטרנט
-
https://permedna.com/
קישור חיצוני עבור Perme DNA Profile
- תעשייה
- Biotechnology Research
- גודל החברה
- 11-50 עובדים
- משרדים ראשיים
- Tel Aviv
- סוג
- בבעלות פרטית
מיקומים
-
הראשי
Tel Aviv, IL
עובדים ב- Perme DNA Profile
-
Assaf Tidhar
4x Founder, Partner, Advisor, Mentor, Chief Revenue Officer at PerMe
-
Yoav Rapaport
CEO and Founder of PerMe | Owner of Elevatione Group | Owner of Remilia Hair | Entrepreneur | Brand Development | International Markets | Customer…
-
Gil Atzmon
BOD Chief Scientist Genetics | Associate Prof. of Medicine and Genetics | Ph.D. in Genetics of Populations | Human Genetics | Epigenetics Researcher |
-
Maayan Insler
PhD Student
עדכונים
-
https://lnkd.in/dZ3qbhis We are delighted to share our participation in today's exclusive Calcalist conference in Miami! 🌟 We presented our audience with PerMe's breakthrough technology, set to revolutionize the DNA testing industry. Our innovative platform delivers enhanced accuracy and faster results at a significantly reduced cost compared to existing market solutions. The overwhelmingly positive feedback we received reinforces our belief that we're on the right track to making DNA testing accessible to everyone. Special appreciation to the Calcalist team for the opportunity to showcase our vision! 💡 Dr. Carina TyrrellRapaportShaul RachmaniGil AtzmonIgal ChertkowAssaf TidharVladimir Vulfin #Biotech #Startup #Innovation #DNA #Miami #Calcalist@
-
PerMe was selected from hundreds of candidates to participate in the startup program of the Calcalist and to showcase its technological innovation in the field of DNA testing to investors and potential customers in Miami, Florida, USA. Dr. Carina TyrrellIgal ChertkowGil AtzmonAssaf TidharYoav RapaportChen Amar Hasson
-
🧬 Breakthrough in Alzheimer’s and Longevity Research by PerMe’s Prof. Gil Atzmon! 🧬 Did you know a small peptide might hold the key to a longer, healthier life for those vulnerable to developing AD dementia (APOE4 carriers)? The key is humanin variant P3S, uncovered in centenarian ‘super-agers’, resists Alzheimer’s brain changes and promotes longevity. 💡 Key Insights from Prof. Gil Atzmon’s study: • • A tiny peptide could be a game-changer for Alzheimer’s and aging. • • The Humanin P3S variant shows promise in boosting brain health and longevity for those at risk. 👉 Learn more about this groundbreaking discovery here. #Alzheimers #Longevity #Genetics #HealthInnovation